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STATE-OF-THE-ART PAPERHSTATE-OF-THE-ART PAPERNon-HDL Compared With ApoB for Cardiovascular Risk Stratification457Vimal Ramjee, Laurence S. Sperling, Terry A. Jacobson
464Richard V. Milani, Carl J. Lavie
Ramjee and colleagues review the data supporting the need to extend lipid risk assessment
and intervention beyond low-density lipoprotein cholesterol (LDL-C), and they compared
the relative strengths and weakness of the 2 prime candidates to replace LDL-C: namely
apolipoprotein (apo)B and non–high-density lipoprotein cholesterol (non–HDL-C). Several
studies have found that both non–HDL-C and apoB perform better than LDL-C in
cardiovascular disease risk prediction both on- and off-treatment, but there is no clear
consensus yet as to which is more accurate. Ramjee and colleagues argue that non–HDL-C is
the current logical replacement for LDL-C because it is widely available on standard lipid
profiles with no additional cost, the results are available quickly, and there are established
cutpoints with safe and achievable goals. Milani and Lavie concur in an accompanying
commentary piece that non–HDL-C should be adopted for the same reasons and to avoid
confusion by emphasizing a new lipid parameter.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
467igh On-Treatment PR After Prasugrel Loading Dose
Is Associated With Increased Risk After PCI for ACSLaurent Bonello, Michel Pansieri, Julien Mancini, Roland Bonello, Luc Maillard, Pierre Barnay,
Philippe Rossi, Omar Ait-Mokhtar, Bernard Jouve, Frederic Collet, Jean Pascal Peyre,
Olivier Wittenberg, Axel de Labriolle, Elise Camilleri, Edouard Cheneau, Elma Cabassome,
Françoise Dignat-George, Laurence Camoin-Jau, Franck Paganelli
High post-treatment platelet reactivity (PR) predicts an increased risk of major adverse
cardiovascular events (MACE) following percutaneous coronary intervention (PCI) for
patients treated with clopidogrel. Bonello and colleagues investigated the relationship between
PR and thrombotic events after percutaneous coronary intervention (PCI) in patients treated
with prasugrel. All patients presented with an acute coronary syndrome (ACS) and were
treated with a 60-mg loading dose of prasugrel. Patients experiencing a thrombotic event
following PCI had a significantly higher vasodilator-stimulated phosphoprotein index
compared with those who did not. Despite the use of prasugrel, a significant number of ACS
patients undergoing PCI do not achieve optimal PR inhibition and are at increased risk of
MACE compared with those who do.(continued on page A-28)
JULY 26, 2011 (continued) A-28SHEART FAILURE474Myocardial Iron Depletion in HFMicha T. Maeder, Ouda Khammy, Cris dos Remedios, David M. Kaye
Maeder and colleagues investigated the pathophysiologic link between anemia and heart
failure (HF). In a series of experiments including hemodynamic, biochemical, and myocardial
biopsy specimens, HF patients displayed evidence of iron deficiency. There was a significant
reduction in the myocardial mRNA expression of type 1 transferrin receptor (Tfr1), which
plays a key role in cellular iron transport. Further studies showed that catecholamines and
aldosterone both down-regulated Tfr1 expression in isolated cardiomyocytes. This study
demonstrates iron depletion in the failing human heart and provides a potential mechanistic
link between anemia and HF.Editorial Comment: John McMurray, Piotr Ponikowski, p. 481CARDIAC RESYNCHRONIZATION THERAPY
483urgical LV Lead Implant May Be Better for Patients
Needing CRT With Unfavorable Cardiac Vein AnatomyFrancesco Giraldi, Gaia Cattadori, Maurizio Roberto, Corrado Carbucicchio, Mauro Pepi,
Giovanni Ballerini, Francesco Alamanni, Paolo Della Bella, Gianluca Pontone, Daniele Andreini,
Claudio Tondo, Piergiuseppe G. Agostoni
The benefits of cardiac resynchronization therapy (CRT) seem to depend on proper
positioning of the left ventricular (LV) lead over the postero-lateral wall. Giraldi and
colleagues performed multislice computed cardiac tomography prior to CRT procedures;
patients with unfavorable coronary sinus (CS) anatomy were randomized to a standard
transvenous approach or surgical LV lead implantation using a minithoracotomy. One year
after CRT, patients randomized to surgery had significant improvements in New York Heart
Association functional class, LV ejection fraction, LV end-systolic volume, and peak VO2/kg,
while there were no improvements in patients who underwent the transvenous approach. In
patients with unfavorable CS branch anatomy, CRT by a surgical approach seems preferable.
Editorial Comment: Kenneth A. Ellenbogen, Jordana Kron, p. 491(continued on page A-29)
JULY 26, 2011 (continued) A-29HEART RHYTHM DISORDERS493Real-World Results of Rhythm- and Rate-Control Therapies for AFA. John Camm, Günter Breithardt, Harry Crijns, Paul Dorian, Peter Kowey, Jean-Yves Le Heuzey, Ihsen Merioua,
Laurence Pedrazzini, Eric N. Prystowsky, Peter J. Schwartz, Christian Torp-Pedersen, William Weintraub
RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial
Fibrillation) is a worldwide, prospective, observational survey of the management of atrial
fibrillation (AF) in unselected, community-based patients. Camm and colleagues used this
database to determine therapeutic success and clinical outcomes associated with rhythm- and
rate-control strategies. Therapeutic success required that strategy (rhythm or rate-control) was
unchanged without clinical events and that the patients were in sinus rhythm at 12-month
electrocardiogram in the rhythm-control group or had a heart rate 80 beats/min in the rate-
control group. Therapeutic success with rhythm control was 60% compared with 47% for rate
control. Clinical events occurred in 18% of patients, but did not differ based on arrhythmia
management strategy. These results help to define the real-world success of rhythm- and
rate-control strategies.CARDIAC IMAGING502MDCT Plaque Imaging Identifies Patients at Increased Risk After NSTEMIThomas S. Kristensen, Klaus F. Kofoed, Jørgen T. Kühl, Walter B. Nielsen, Michael B. Nielsen, Henning Kelbæk
Kristensen and colleagues sought to determine whether the amount of noncalcified plaque in
nonobstructive coronary lesions as detected by multidetector computed tomography (MDCT)
was a predictor of future coronary events in patients presenting with non–ST-segment
elevation myocardial infarction (NSTEMI). Over 300 NSTEMI patients underwent MDCT
and coronary artery calcium scoring before invasive coronary angiography. During a median
follow-up of 16 months, 23 patients suffered a cardiac event. In a multivariate regression
analysis, the total amount of noncalcified plaque was independently associated with an
increased risk of recurrent events.Editorial Comment: William Wijns, Joanne D. Schuijf, p. 520CARDIAC IMAGING510Extent of Nonobstructive CAD on CTA Is Associated With Higher MortalityFay Y. Lin, Leslee J. Shaw, Allison M. Dunning, Troy M. LaBounty, Jin-Ho Choi,
Jonathan W. Weinsaft, Sunaina Koduru, Millie J. Gomez, Augustin J. Delago, Tracy Q. Callister,
Daniel S. Berman, James K. Min
Lin and colleagues examined the prognostic significance of nonobstructive coronary plaques
detected on coronary computed tomographic angiography (CCTA). Consecutive adults
without prior documented coronary artery disease (CAD) and without obstructive (50%)
CAD by CCTA were followed for a median of 3 years. After adjustment for CAD risk
factors, the presence of any nonobstructive plaque was associated with a 2-fold higher
mortality rate; the risk of mortality was also incremental with the extent of CAD. The
presence and extent of nonobstructive plaques augments prediction of cardiac mortality above
and beyond conventional clinical risk assessment.Editorial Comment: William Wijns, Joanne D. Schuijf, p. 520
(continued on page A-35)
JULY 26, 2011 (continued) A-35BIOMARKERS522Pre-Operative BNP Predicts Operative Risk in Vascular Surgery PatientsReitze N. Rodseth, Giovana A. Lurati Buse, Daniel Bolliger, Christoph S. Burkhart,
Brian H. Cuthbertson, Simon C. Gibson, Elisabeth Mahla, David W. Leibowitz, Bruce M. Biccard
Rodseth and colleagues investigated the utility of pre-operative measurement of B-type
natriuretic peptides (BNPs) to predict post-operative complications related to vascular surgery.
Six datasets were combined for an individual patient data meta-analysis with almost 800
individuals. An elevated BNP level was associated with a nearly 8 times higher risk for death
or nonfatal myocardial infarction within 30 days of surgery. Pre-operative measurement of
BNPs can independently predict cardiovascular events after vascular surgery and significantly
improve revised cardiac risk index (RCRI) predictive performance.LIPID-LOWERING THERAPY530No Evidence of Increased Cancer Risk With StatinsClaudio Marelli, Candace Gunnarsson, Susan Ross, Sara Haas, Donna F. Stroup,
Paul Cload, Paul Clopton, Anthony N. DeMaria
Statins are widely prescribed drugs, but there is an ongoing debate about the association of
statins with cancer. Marelli and colleagues performed a retrospective cohort analysis of the
incidence of cancer in older adults who have and who have not used statins. More than 11
million patient records were reviewed from a large electronic medical records database with
propensity matching of patients receiving and not receiving statins. There were 45,857
comparison pairs of statin versus nonstatin patients, with an average follow-up of almost 5
years. There was no difference in the incidence of total cancer or of any specific type of
cancer. This retrospective analysis suggests that there is no association between statin use and
the risk of developing cancer.CONGENITAL HEART DISEASE538Pulmonary Hypertension Increases Mortality in Adults With CHDBoris S. Lowe, Judith Therrien, Raluca Ionescu-Ittu, Louise Pilote, Giuseppe Martucci,
Ariane J. Marelli
Lowe and colleagues investigated the impact of pulmonary hypertension (PH) on outcomes
of adults with congenital heart disease (CHD). Using a large database of CHD patients in
Ontario, Canada, the prevalence of PH was 5.8% in this population. Using matched-pair
analysis including type of CHD, a diagnosis of PH was associated with a 2.7-fold higher risk
of mortality, as well as increased risks of heart failure, arrhythmias, and utilization of medical
services. PH is associated with significantly higher morbidity and mortality in adults with
CHD.
